58 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

LLY

Eli Lilly
US$690.000%81.6%US$664.0bUS$761.25PE126.7xE27.0%0.7%

NOVOB

Novo Nordisk
kr.86.710%45.7%kr.3.1tkr.86.54PE40.7xE15.2%1.0%

943981

Johnson & Johnson
US$133.64-2.4%-8.2%US$353.8bUS$158.01PE18.5xE5.1%3.4%

10683053

Merck
US$119.663.2%16.1%US$329.6bUS$129.59PE142.9xE26.1%2.4%

982352

AstraZeneca
UK£138.959.0%2.8%UK£187.0bUK£151.42PE36.9xE16.6%2.1%

NOVN

Novartis
CHF89.050.1%-3.4%CHF181.3bCHF98.87PE21.9xE10.1%3.7%

NOVNEE

Novartis
CHF89.620.02%-3.1%CHF181.7bCHF101.85PE21.7xE10.1%3.7%

ROG

Roche Holding
CHF220.60-4.0%-21.4%CHF178.5bCHF279.06PE15.3xE8.8%4.4%

RO

Roche Holding
CHF240.80-3.8%-20.5%CHF178.5bCHF304.61PE15.3xE8.8%4.4%

907582

Amgen
US$226.360%n/aUS$145.8bUS$229.35PE19.3xE5.7%3.1%

935700

Gilead Sciences
US$68.480%10.5%US$94.1bUS$82.84PE17.2xE7.8%4.0%

BMY

Bristol-Myers Squibb
US$54.240%0%US$90.5bUS$65.32PS2xE43.0%5.4%

CSJ

CSL
AU$163.97-0.03%n/aAU$133.7bAU$180.93PE35.3xE14.7%1.3%

1102657

GSK
UK£26.120%-2.8%UK£70.6bUK£34.09PE13.8xE8.9%5.7%

MER

Merck KGaA
€147.03-4.6%n/a€65.2b€179.65PE22.9xE9.9%1.5%

MER

Merck KGaA
€228.300%n/a€65.2b€278.96PE22.9xE9.9%1.5%

0QF

Moderna
US$184.330%40.6%US$53.4bUS$293.47PE6.4xE-15.5%n/a

LONN

Lonza Group
CHF510.40-3.0%-7.8%CHF36.8bCHF566.00PE56.3xE20.2%0.8%

LONNE

Lonza Group
CHF513.80-2.9%-7.3%CHF36.8bCHF569.77PE56.3xE20.2%0.8%

BIIB

Biogen
US$222.000%0%US$31.4bUS$294.59PE26.9xE17.8%n/a

BAYN

Bayer
€67.99-64.2%-66.0%€27.1b€91.74PB0.8xE46.3%0.4%

22UA

BioNTech
US$80.220.2%n/aUS$21.2bUS$104.04PE21.2xE-20.2%n/a

GALD

Galderma Group
CHF68.502.6%n/aCHF16.3bn/an/an/an/a

UNC

UCB
€77.910%n/a€16.3b€87.27PE38.8xE24.8%1.5%
Page 1 of 3
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.